Recent Updates
Recently added Catalysts
SBC Neutral Sentiment

日経マネー 資産運用＆IRフォーラム in 関西2026

Wednesday, May 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article provides an overview of SBC's investor relations activities and stock information, including financial details and corporate governance. It outlines various aspects such as SEC filings, quarterly results, and upcoming events. However, it lacks specific news or developments that could influence investor sentiment.
Price reaction · baseline $3.12 (2026-05-26 close) · hit after-hours · 1 other SBC headline(s) in the window, move may be shared
day 0 close
-0.6%

Market Sentiment Analysis

Full Press Release Details

• Overview
• Stock Info. Stock Info. Analyst Coverage
• Financial Info. SEC Filings Quarterly Results Proxy Statements
• Corporate Governance Board of directors Board committees Annual Meetings of Stockholders
• News Press Releases IR Information
• Events & Presentations Events Presentations Presentation Videos
• Contact / Q&A Contact IR Email Alerts FAQs
• Stock Info.
• Analyst Coverage
• SEC Filings
• Quarterly Results
• Proxy Statements
• Board of directors
• Board committees
• Annual Meetings of Stockholders
• Press Releases
• IR Information
• Events
• Presentations
• Presentation
• Videos
• Contact IR
• Email Alerts
• FAQs

日経マネー 資産運用＆IRフォーラム in 関西2026

ShareAdd on Google
Tags: SBC Viatris Investor Conferences Healthcare investor relations financial info corporate governance SEC filings
Last updated: May 27, 2026

Biotech snapshot

Cash runway
$168M liquidity · $0M/mo burn
Low dilution risk